metastatic breast cancer

Showing NaN - NaN of 64

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)

Completed
  • Metastatic Breast Cancer
  • Placebo
  • +4 more
  • Birmingham, Alabama
  • +119 more
Sep 27, 2021

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Metastatic Breast Cancer Trial in New York (Ad-RTS-hIL-12, Veledimex)

Completed
  • Metastatic Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 30, 2021

Associated With First-Line CDK4/6 Inhibition and Hormonal

Not yet recruiting
  • Metastatic Breast Cancer
  • Palbociclib + aromatase inhibitor
  • Aromatase inhibitor
  • New York, New York
    Pfizer
Sep 7, 2021

Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in United States (PMD-026)

Recruiting
  • Metastatic Breast Cancer
  • Triple Negative Breast Cancer
  • Gilbert, Arizona
  • +8 more
Aug 20, 2021

Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))

Completed
  • Locally Recurrent Breast Cancer
  • Metastatic Breast Cancer
  • NKTR-102
  • Treatment of Physician's Choice (TPC)
  • Flagstaff, Arizona
  • +152 more
May 6, 2021

Metastatic Breast Cancer Trial in Worldwide (Atezolizumab, Trastuzumab emtansine, Placebo)

Completed
  • Metastatic Breast Cancer
  • Orange, California
  • +67 more
Jan 28, 2021

Metastatic Breast Cancer, CNS (CNS) Metastases Trial in United States (Lapatinib in Tandem With Capecitabine)

Completed
  • Metastatic Breast Cancer
  • Central Nervous System (CNS) Metastases
  • Lapatinib in Tandem With Capecitabine
  • Ann Arbor, Michigan
  • +8 more
Jan 25, 2021

Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • Breast Carcinoma
  • New York, New York
    Columbia Irving University Medical Center
Jan 5, 2021

Metastatic Breast Cancer, Locally Recurrent Breast Cancer Trial in Worldwide (Eribulin, Balixafortide)

Unknown status
  • Metastatic Breast Cancer
  • Locally Recurrent Breast Cancer
  • Fresno, California
  • +87 more
Nov 26, 2020

Metastatic Breast Cancer Trial in Worldwide (OPT-822/OPT-821(30 µg/100 µg), Phosphate Buffer Saline (PBS), Cyclophosphamide)

Completed
  • Metastatic Breast Cancer
  • OPT-822/OPT-821(30 μg/100 μg)
  • +2 more
  • Birmingham, Alabama
  • +42 more
Sep 14, 2020

Breast Cancer, Metastatic Breast Cancer, MBC Trial in United States (Lucitanib)

Terminated
  • Breast Cancer
  • +7 more
  • Sedona, Arizona
  • +32 more
Jun 20, 2020

Metastatic Breast Cancer Trial in Worldwide (Abemaciclib)

Completed
  • Metastatic Breast Cancer
  • Sedona, Arizona
  • +35 more
Jan 10, 2020

Metastatic Breast Cancer Trial in Worldwide (Pertuzumab, Placebo, Trastuzumab)

Completed
  • Metastatic Breast Cancer
  • Scottsdale, Arizona
  • +321 more
Dec 12, 2019

Metastatic Breast Cancer Trial in New York (Radiation therapy, Study Drug)

Terminated
  • Metastatic Breast Cancer
  • Radiation therapy
  • Study Drug
  • New York, New York
    Weill Cornell Medical College
Nov 20, 2019

Metastatic Breast Cancer Trial in Los Angeles, New York (Fresolimumab, Radiation Therapy)

Completed
  • Metastatic Breast Cancer
  • Los Angeles, California
  • +1 more
Feb 21, 2019

Cancer of the Breast, Breast Cancer, Advanced Breast Cancer Trial in United States (Seviteronel)

Completed
  • Cancer of the Breast
  • +6 more
  • Birmingham, Alabama
  • +35 more
Jan 31, 2019

Metastatic Breast Cancer Trial in Spain, United States (POL6326)

Completed
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +11 more
Sep 13, 2018

Metastatic Breast Cancer Trial in New York (ixabepilone)

Completed
  • Metastatic Breast Cancer
  • New York, New York
    Weill Medical College of Cornell University
May 31, 2018

Metastatic Breast Cancer Trial in United States (IMC-A12 (cixutumumab), tamoxifen, Anastrozole)

Completed
  • Metastatic Breast Cancer
  • IMC-A12 (cixutumumab)
  • +5 more
  • Scottsdale, Arizona
  • +8 more
May 2, 2018

Metastatic Breast Cancer Trial in United States (Fulvestrant, Everolimus, Placebo)

Completed
  • Metastatic Breast Cancer
  • Greenbrae, California
  • +24 more
Apr 30, 2018

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

Circulating Tumor Cells From Metastatic Breast Cancer Using

Completed
  • Metastatic Breast Cancer
  • Blood collection
  • Phoenix, Arizona
  • +19 more
Mar 7, 2017